Arqule (ARQL) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
ArQule Reports First Quarter 2015 Financial Results
May 6, 2015 7:00 AM EDTConference call scheduled today at 9:00 a.m. eastern time
WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the first quarter of 2015.
For the quarter ended March 31, 2015, the Company reported a net loss of $4,551,000 or $0.07 per share, compared to a net loss of $7,141,000 or $0.11 per share, for the first quarter of 2014.
At March 31, 2015, the Company had a total of $53,581,000 in cash, equivalents and marketable securities.
Operational Update
Enrollment in the pivotal Phase 3 METIV-HCC... MoreArQule and Beryllium Announce Collaborative Research and Development Agreement
May 5, 2015 8:30 AM EDTParties to Focus on Immuno-Oncology Targets
Collaboration Provides for Target Screening Through Clinical Development and Commercialization of Priority Compounds
Agreement Leverages Applications of Beryllium Platforms to Validate Drug Targets and New Therapies
WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (NASDAQ: ARQL) and Beryllium Discovery Corp. today announced a collaborative research and development agreement to identify and unlock the therapeutic potential of small molecule compounds by combining ArQules chemistry and drug development expertise with Berylliums discovery platforms. The Beryllium platforms integrate... More
